Shenoy-Bhangle Anuradha, Baliyan Vinit, Kordbacheh Hamed, Guimaraes Alexander R, Kambadakone Avinash
Beth Israel Deaconess Medical Center, Boston, MA 02215, United States.
Harvard Medical School, Abdominal Imaging and Interventional Radiology, Massachusetts General Hospital, Boston, MA 02114, United States.
World J Hepatol. 2017 Sep 18;9(26):1081-1091. doi: 10.4254/wjh.v9.i26.1081.
Diffusion-weighted imaging (DWI), a functional imaging technique exploiting the Brownian motion of water molecules, is increasingly shown to have value in various oncological and non-oncological applications. Factors such as the ease of acquisition and ability to obtain functional information in the absence of intravenous contrast, especially in patients with abnormal renal function, have contributed to the growing interest in exploring clinical applications of DWI. In the liver, DWI demonstrates a gamut of clinical applications ranging from detecting focal liver lesions to monitoring response in patients undergoing serial follow-up after loco-regional and systemic therapies. DWI is also being applied in the evaluation of diffuse liver diseases such as non-alcoholic fatty liver disease, hepatic fibrosis and cirrhosis. In this review, we intend to review the basic principles, technique, current clinical applications and future trends of DW-MRI in the liver.
扩散加权成像(DWI)是一种利用水分子布朗运动的功能成像技术,越来越多地显示出在各种肿瘤学和非肿瘤学应用中的价值。诸如采集简便以及在无需静脉注射造影剂的情况下获取功能信息的能力等因素,尤其是在肾功能异常的患者中,促使人们对探索DWI的临床应用兴趣日益浓厚。在肝脏方面,DWI展示了一系列临床应用,从检测肝脏局灶性病变到监测局部和全身治疗后接受连续随访患者的反应。DWI也正应用于弥漫性肝脏疾病如非酒精性脂肪性肝病、肝纤维化和肝硬化的评估。在这篇综述中,我们旨在回顾肝脏扩散加权磁共振成像(DW-MRI)的基本原理、技术、当前临床应用及未来趋势。